The Michael J. Fox Foundation for Parkinson’s Research has partnered with Grifols, a global healthcare company, to identify ...

A 47-year-old man was the first in the world to be treated outside of a study context with a new technique for the symptoms ...

The US company has said it is launching the Phase III trials in the first half of this year after Phase I talks with the US ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Delray Medical Center cut the ribbon on its newest high-tech machine that targets brain areas to treat movement disorders ...

In the past, Parkinson’s disease was primarily considered a disorder of the nervous system, centered in the brain. However, ...

Learn how caffeine affects Parkinson's disease prevention and treatment. New research uncovers both protective benefits and treatment limitations.

Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to ...

Treatment with an oral allosteric modulator was nonsuperior to placebo at 6 weeks in adults with Parkinson’s disease whose ...

Parkinson's disease is a solvable problem, but only if we act decisively and urgently. We have the knowledge, and we've built ...

A new discovery in blood immune cells has put researchers one step closer to identifying a blood biomarker that would allow ...

University of Arizona researchers revealed that dyskinesia in Parkinson’s patients stems from a disconnect in the motor ...